Product logins

Find logins to all Clarivate products below.


Trauma Devices | Market Insights | Europe (Supplemental) | 2023

Compared to other major orthopedic device markets, the European trauma device market has been somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma cases. Following the impact of the pandemic, financial constraints and the increasing presence of GPOs will contribute to downward ASP pressure, limiting revenue growth to some extent, although favorable demographics, improving reimbursement, site-of-service flexibility, and ongoing product innovation will support procedure volumes.

This Medtech 360 Report provides high-level market metrics for trauma devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2031.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Dental Implants – Market Insights – Europe
The European dental implant market is projected to experience modest expansion through 2035. Growth is driven by an aging population with ongoing long-term restorative needs, a persistent burden of…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…